We also examined Mtb susceptibility to isoniazid (INH), another first-line anti-TB drug which is predominantly metabolized (50–90%) via N-acetylation of its hydrazine functionality by arylamine N-acetyltransferase 2 (NAT2) (Sotsuka et al., 2011). Here, NAT2 is linked to tuberculosis.